< 生产厂家价格 >

2-吗啉代乙基异腈

2-吗啉代乙基异腈用途

【用途一】
非常有潜力的多肽缩合剂，与DCC相比可以获得较高的得率，产物消旋较小[1,2]；Reagent used in a Passerini-like reaction to alpha-hydroxy amides。

点击显示

2-吗啉代乙基异腈名称

[ CAS 号 ]:
78375-48-1

[ 中文名 ]:
2-吗啉代乙基异腈

[ 英文名 ]:
4-(2-Isocyanoethyl)morpholine

[中文别名 ]:

2-吗啉基乙基异腈

[英文别名 ]:

MFCD00040506
4-(2-Isocyanoethyl)morpholine
Morpholine, 4-(2-isocyanoethyl)-

2-吗啉代乙基异腈物理化学性质

[ 密度 ]:
1.017 g/mL at 20 °C(lit.)

[ 沸点 ]:
72-73 °C0.7 mm Hg(lit.)

[ 分子式 ]:
C₇H₁₂N₂O

[ 分子量 ]:
140.183

[ 闪点 ]:
110ºC

[ 精确质量 ]:
140.094955

[ PSA ]:
12.47000

[ 折射率 ]:
n20/D 1.469

[ 储存条件 ]:
−20°C

2-吗啉代乙基异腈安全信息

[ 符号 ]:

GHS06

[ 信号词 ]:
Danger

[ 危害声明 ]:
H301-H311-H315-H319-H331-H335

[ 警示性声明 ]:
P261-P280-P301 + P310-P305 + P351 + P338-P311

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
T:Toxic;

[ 风险声明 (欧洲) ]:
R23/24/25;R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36/37-S45

[ 危险品运输编码 ]:
UN 2810 6.1/PG 3

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1(b)

[ 海关编码 ]:
2934999090

2-吗啉代乙基异腈合成路线

详细合成路线

2-吗啉代乙基异腈上下游产品

2-吗啉代乙基异腈上游产品

2-吗啉代乙基异腈下游产品

2-吗啉代乙基异腈海关

[ 海关编码 ]: 2934999090

[ 中文概述 ]:
2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

2-吗啉代乙基异腈文献

[Syntheses of human little gastrin-I and its leucine-15, norleucine-15 and methoxinine-15 analogs].

Hoppe. Seylers. Z. Physiol. Chem. 364 , 157, (1983)

Human little gastrin-I is known to exhibit a high tendency to air-oxidation of its methionine-15 residue to the corresponding S-oxide derivative, with concomitant loss of biological activity. Since it...

Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.

BMC Immunol. 16 , 29, (2015)

Scavenger receptor A (SRA) is expressed predominantly in phagocytic cells playing an essential role in the host immune defense against invading microorganisms. Our previous study reported the presence...

Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity.

Biochem. Biophys. Res. Commun. 464 , 1185-91, (2015)

Some patients with chronic hepatitis B (CHB) receiving entecavir (ETV) exhibit partial virological response (PVR) to ETV and the mechanism is not clear. In this study, we aim to investigate the in vit...

更多文献